{
    "nctId": "NCT04798976",
    "briefTitle": "Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer",
    "officialTitle": "Personalized Evidence-based Treatment Improves Survival in Patients With Invasive Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer-specific Survival",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 3000,
    "primaryOutcomeMeasure": "The percentage of guideline-consistent and personalized EBM recommendations",
    "eligibilityCriteria": "Inclusion Criteria:\n\nAll women with stage I-III disease who survived at least 12 months post-diagnosis\n\nExclusion Criteria:\n\nUnknown cause of death Treatment outside the region (thus precluding the treatment assessment)",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}